Gene · 23013
Papers1,651
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,651
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Molecular characterization and clonal evolution in Richter transformation: Insights from a case of plasmablastic lymphoma (RT-PBL) arising from chronic lymphocytic leukaemia (CLL) and review of the literature. | EJHaem | 2023 | 38024595 | PubTator, text mining | PubMed |
| Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study. | Cell Rep Med | 2023 | 38016482 | PubTator, text mining | PubMed |
| State-of-the-Art Cancer Biology, Biodiagnostics and Therapeutics in Japan. | Biomedicines | 2023 | 38001906 | PubTator, text mining | PubMed |
| CRISPR/Cas9: a powerful tool in colorectal cancer research. | J Exp Clin Cancer Res | 2023 | 37993945 | PubTator, text mining | PubMed |
| Cisplatin increases carboxylesterases through increasing PXR mediated by the decrease of DEC1. | J Biomed Res | 2023 | 37990879 | PubTator, text mining | PubMed |
| IndiSPENsable for X Chromosome Inactivation and Gene Silencing. | Epigenomes | 2023 | 37987303 | PubTator, text mining | PubMed |
| mTOR inhibition suppresses salinomycin-induced ferroptosis in breast cancer stem cells by ironing out mitochondrial dysfunctions. | Cell Death Dis | 2023 | 37968262 | PubTator, text mining | PubMed |
| Effectiveness and Safety of the PD-1 Inhibitor Lenvatinib Plus Radiotherapy in Patients with HCC with Main PVTT: Real-World Data from a Tertiary Centre. | J Hepatocell Carcinoma | 2023 | 37965075 | PubTator, text mining | PubMed |
| Insights into the regulatory role of RNA methylation modifications in glioma. | J Transl Med | 2023 | 37964279 | PubTator, text mining | PubMed |
| Innovations in social health delivery to advance equitable pediatric and adolescent life course health development: A review and roadmap forward. | Curr Probl Pediatr Adolesc Health Care | 2023 | 37957084 | PubTator, text mining | PubMed |
| Deletion in 1p36.33-p36.32 is associated with pancytopenia: a case report. | BMC Med Genomics | 2023 | 37946214 | PubTator, text mining | PubMed |
| SHARP wit: Why receiving sarcasm improves perspective-taking. | Curr Opin Psychol | 2023 | 37939568 | PubTator, text mining | PubMed |
| N7-methylguanosine-related miRNAs predict hepatocellular carcinoma prognosis and immune therapy. | Aging (Albany NY) | 2023 | 37925170 | PubTator, text mining | PubMed |
| Feasibility of a community-adapted multi-domain intervention for dementia prevention among older adults: a research protocol. | Arch Public Health | 2023 | 37907936 | PubTator, text mining | PubMed |
| Unlocking the Viral Universe: Metagenomic Analysis of Bat Samples Using Next-Generation Sequencing. | Microorganisms | 2023 | 37894190 | PubTator, text mining | PubMed |
| Phenotypic and Genomic Characterization of the Comune di Sicilia Goat: Towards the Conservation of an Endangered Local Breed. | Animals (Basel) | 2023 | 37893931 | PubTator, text mining | PubMed |
| High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphoma. | Blood Adv | 2023 | 37862676 | PubTator, text mining | PubMed |
| Next-generation sequencing in dermatology. | Front Med (Lausanne) | 2023 | 37841001 | PubTator, text mining | PubMed |
| Outcomes of Patients with Advanced Hepatocellular Carcinoma Receiving Lenvatinib following Immunotherapy: A Real World Evidence Study. | Cancers (Basel) | 2023 | 37835561 | PubTator, text mining | PubMed |
| The Glioblastoma CircularRNAome. | Int J Mol Sci | 2023 | 37833993 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23013/papers?page=8